Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet    (TORR)


FREE Event: The Great Indian Wealth Project


Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 2,716.8
Mkt Cap Rs m 459,846
Vol '000 11.4
P/E X 38.4
P/CF X 43.6
EPS (TTM) Rs 70.7
% ch % -1.8
No. of shares m 169.26
% ch week % 8.3
% ch 1-mth % 5.4
% ch 12-mth % 15.3
52 week H/L Rs 3,040.0/2,232.0
(As on May 11, 2021 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs1,2321,7201,7681,5501,964 
Low Rs5231,1341,1861,1441,245 
Sales per share (Unadj.) Rs275.0394.5346.1351.6453.4 
Earnings per share (Unadj.) Rs44.4102.455.240.125.8 
Diluted earnings per shareRs44.4102.455.240.125.8 
Cash flow per share (Unadj.) Rs55.6116.573.364.262.3 
Dividends per share (Unadj.) Rs11.2540.0014.0014.0017.00 
Adj. dividends per shareRs11.2539.9914.0014.0017.00 
Dividend yield (eoy) %1.32.80.91.01.1 
Book value per share (Unadj.) Rs156.2206.5257.1273.1279.2 
Adj. book value per shareRs156.1206.4257.0273.1279.1 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.23.64.33.83.5 
Avg P/E ratio x19.813.926.833.662.2 
P/CF ratio (eoy) x15.812.320.121.025.8 
Price / Book Value ratio x5.66.95.74.95.7 
Dividend payout %25.439.125.434.965.9 
Avg Mkt Cap Rs m148,465241,435249,887227,897271,513 
No. of employees `00011.010.911.814.713.6 
Total wages/salary Rs m8,4188,4249,93411,35314,038 
Avg. sales/employee Rs Th4,212.46,129.64,971.54,047.55,642.6 
Avg. wages/employee Rs Th762.0773.4843.2772.31,032.4 
Avg. net profit/employee Rs Th679.81,591.3792.4461.3320.9 
TORRENT PHARMA INCOME DATA
Net Sales Rs m46,53566,76458,56959,49876,728 
Other income Rs m2,8562,2562,2332,988571 
Total revenues Rs m49,39069,02060,80262,48777,299 
Gross profit Rs m10,20227,33013,77313,49319,831 
Depreciation Rs m1,9072,3763,0694,0866,177 
Interest Rs m1,7521,8402,0563,0855,038 
Profit before tax Rs m9,39825,37110,8819,3109,187 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0-1,93600-3,570 
Tax Rs m1,8886,1021,5452,5291,254 
Profit after tax Rs m7,50917,3339,3366,7814,363 
Gross profit margin %21.940.923.522.725.8 
Effective tax rate %20.124.114.227.213.6 
Net profit margin %16.126.015.911.45.7 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m40,98346,88248,79452,62350,375 
Current liabilities Rs m27,04632,85527,38352,02251,653 
Net working cap to sales %30.021.036.61.0-1.7 
Current ratio x1.51.41.81.01.0 
Inventory Days Days84749712192 
Debtors Days Days12579597768 
Net fixed assets Rs m34,72039,00742,07985,01683,648 
Share capital Rs m846846846846846 
"Free" reserves Rs m25,58334,09542,65545,37646,397 
Net worth Rs m26,43034,94143,50146,22247,244 
Long term debt Rs m21,72918,50122,40841,11539,129 
Total assets Rs m79,64190,57997,021142,432141,209 
Interest coverage x6.414.86.34.02.8 
Debt to equity ratio x0.80.50.50.90.8 
Sales to assets ratio x0.60.70.60.40.5 
Return on assets %11.621.211.76.96.7 
Return on equity %28.449.621.514.79.2 
Return on capital %23.247.319.614.212.3 
Exports to sales %30.443.3000 
Imports to sales %6.06.9000 
Exports (fob) Rs m14,13628,934000 
Imports (cif) Rs m2,8014,584000 
Fx inflow Rs m14,26529,18520,06614,58022,103 
Fx outflow Rs m5,1846,0215,3043,6005,522 
Net fx Rs m9,08123,16514,76210,98016,581 
TORRENT PHARMA CASH FLOW
From Operations Rs m 8,102 27,421 10,088 8,942 17,981 
From Investments Rs m -21,623 -8,379 -7,869 -47,070 -2,413 
From Financial Activity Rs m 12,123 -14,352 -1,929 34,174 -13,145 
Net Cashflow Rs m -1,399 4,375 177 -3,655 2,380 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   WYETH  SUVEN LIFE SCIENCES  NOVARTIS  ALKEM LABORATORIES  SUN PHARMA  

Compare TORRENT PHARMA With:   WYETH  SUVEN LIFE SCIENCES  NOVARTIS  ALKEM LABORATORIES  SUN PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - DISHMAN PHARMA COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS